TY - JOUR
T1 - Identification of risk factors associated with hyponatremia in psychiatric patients
T2 - a casecontrol study
AU - Powle, Himani
AU - Shet, Ashvitha
AU - Mendonca, Arline
AU - Thulasi, Lakshmi
AU - Poojari, Pooja
AU - Thunga, Girish
AU - Munoli, Ravindra
AU - Kunhikatta, Vijayanarayana
N1 - Funding Information:
We would like to thank the Manipal Academy of Higher Education (MAHE), Manipal College of Pharmaceutical Sciences and the Department of Psychiatry, Kasturba Medical College, Manipal for providing necessary facilities for carrying out this study. We also acknowledge Manipal Universal Press, Manipal for providing English language editing service for this manuscript.
Publisher Copyright:
© This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License https://creativecommons.org/licenses/by-nc-nd/4.0/
PY - 2022
Y1 - 2022
N2 - Background and aims. Prompt recognition and optimal management of hyponatremia helps the physician devise a better treatment plan to prevent future complications in patients. Hence this study aims to identify the risk factors associated with hyponatremia in psychiatric patients. Methods. A case-control study was conducted among psychiatric inpatients in a tertiary care teaching hospital. Patients admitted from January 2013 to December 2017 were identified using ICD-10 code F01-F99. Patients with serum sodium levels < 135 mmol/L were considered to have hyponatremia and between 135-145 mmol/L as controls. Factors associated with hyponatremia were identified by multiple logistic regression, and the odds ratio (OR) was calculated. Results. Based on the inclusion and exclusion criteria, 264 cases of hyponatremia and 253 matching controls were included in the study. The mean age of patients with hyponatremia was 56.4 ± 16.8 years compared to 39.6 ± 13.9 years in controls, and 65.7% of them were males. Seizure disorder (OR = 3.14, p = 0.047), bipolar disorder (OR = 6.03, p = 0.001), depression (OR = 4.78, p = 0.0005), use of quetiapine (OR = 2.11, p = 0.007) and insulin (OR = 3.53, p = 0.038) were independent risk factors associated with development of hyponatremia. Conclusions. The chances of developing hyponatremia are increased in psychiatric patients with a seizure disorder, bipolar disorder, depression and using quetiapine or insulin. And they should be monitored carefully.
AB - Background and aims. Prompt recognition and optimal management of hyponatremia helps the physician devise a better treatment plan to prevent future complications in patients. Hence this study aims to identify the risk factors associated with hyponatremia in psychiatric patients. Methods. A case-control study was conducted among psychiatric inpatients in a tertiary care teaching hospital. Patients admitted from January 2013 to December 2017 were identified using ICD-10 code F01-F99. Patients with serum sodium levels < 135 mmol/L were considered to have hyponatremia and between 135-145 mmol/L as controls. Factors associated with hyponatremia were identified by multiple logistic regression, and the odds ratio (OR) was calculated. Results. Based on the inclusion and exclusion criteria, 264 cases of hyponatremia and 253 matching controls were included in the study. The mean age of patients with hyponatremia was 56.4 ± 16.8 years compared to 39.6 ± 13.9 years in controls, and 65.7% of them were males. Seizure disorder (OR = 3.14, p = 0.047), bipolar disorder (OR = 6.03, p = 0.001), depression (OR = 4.78, p = 0.0005), use of quetiapine (OR = 2.11, p = 0.007) and insulin (OR = 3.53, p = 0.038) were independent risk factors associated with development of hyponatremia. Conclusions. The chances of developing hyponatremia are increased in psychiatric patients with a seizure disorder, bipolar disorder, depression and using quetiapine or insulin. And they should be monitored carefully.
UR - http://www.scopus.com/inward/record.url?scp=85143793847&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85143793847&partnerID=8YFLogxK
U2 - 10.15386/mpr-2368
DO - 10.15386/mpr-2368
M3 - Article
AN - SCOPUS:85143793847
SN - 2602-0807
VL - 95
SP - 430
EP - 437
JO - Medicine and Pharmacy Reports
JF - Medicine and Pharmacy Reports
IS - 4
ER -